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1. Introduction
Schistosomiasis is a parasite chronic disease caused by the helminth of genus Schistosoma. The
infection is common in parts of Africa, South America, Middle East, Caribbean and Asia where
it is a leading cause of morbidity and mortality [1]. Recent estimates suggest there are 700
million people at risk worldwide with almost 200 million infected in Africa alone [2]. In Brazil,
the schistosomiasis infection is caused by Schistosoma mansoni, where estimates suggest a range
from 2.5 million [3, 4] to 12 million people infected [5]. In the state of Minas Gerais, schistoso‐
miasis mansoni is prevalent in 519 out of 853 municipalities, with an estimated number of one
million infected people in an area of 300.000 km² [6].
One of the greatest public health problems in countries where the disease is highly endemic,
including Brazil, is schistosomiasis control for the following reasons: (a) large intermediary
hosts dissemination and their escape mechanisms from molluscicides and from biological
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control due to high costs and low efficacy; (b) high charges associated with implementation of
sanitary conditions and water supply and the intense contact of rural population with polluted
water, as well as engagement in agricultural and fishing activities; (c) the long time needed for
sanitary education and for the community to adhere to controlling programs; (d) individual
or massive treatment has been shown efficient for controlling the morbidity, but not for
reducing prevalence due to reinfection; (e) individual protection is unlikely, except for specific
groups of exposed people; (f) until the current days, there is no effective vaccine for preventing
schistosomiasis [7, 8].
According  to  previous  data  published  by  our  group  [9,  10],  the  proliferation  of  rural
tourism  in  endemic  areas  may  be  an  important  contributing  factor  to  the  outbreak  of
schistosomiasis cases. The preservation of natural environment on the site, in order to at‐
tract visitors from urban centers, unintentionally contributes to create an ideal habitat for
the intermediate host. Additionally, most areas chosen for leisure activities accommodate
rural  communities without any type of  sanitation and,  thus,  represent a permanent risk
of contamination of the flowing water.
In this context, visitors from urban areas, who never had previous contact with the parasite,
contract the infection, and develop acute schistosomiasis [11]. Acute schistosomiasis is
associated with a primary exposure and is more commonly seen in non-immune individuals
traveling through endemic regions [12]. The clinical symptoms most commonly observed in
such patients include fever, general weakness, headache, nausea, vomiting, diarrhea, anorexia,
colic, weight loss, dry cough and hepatosplenomegaly accompanied by marked eosinophilia
and leucocytosis [13-16]. However, these clinical symptoms may be confused with a number
of infections such as visceral leishmaniasis, typhoid fever, malaria, tuberculosis, viral hepatitis,
mononucleosis and bacterial infections [17]. Hence, the diagnosis of acute schistosomiasis
becomes a challenge for the assistant doctor due to the wide diversity of non-specific symptoms
presented by the patients; in addition, the presence of eggs in stool may not to be easily detected
by parasitological examination in this phase of the infection.
Abdominal ultrasound is a complementary tool often used to assist the diagnoses of the
S. mansoni  infection, mainly on the study of the liver damage caused by the chronic in‐
fection. It is an inexpensive method, not radioactive or invasive, which provides immedi‐
ate results and can be used for epidemiological fieldwork in endemic areas. The hepatic
ultrasound pattern in patients with severe hepatosplenic schistosomiasis is  characterized
by pronounced periportal thickening. However, reports of ultrasound studies in patients
with acute schistosomiasis are still scarce [18], and additional trials are necessary to eval‐
uate the benefits and limitations of the ultrasound as a tool of clinical  evaluation at the
acute phase of the S. mansoni infection [19].
From the immunological point of view, the acute phase of the infection is characterized
by a series of humoral and cellular immunological events. Hiatt et al. [20] showed eleva‐
tions of IgG, IgM, IgE, and high titers of total antibodies in serum of acute patients that
indicated the illness is  associated with intense immune activity,  while the magnitude of
the  IgE  responses  was  related  to  the  intensity  of  the  infection.  De  Jesus  et  al.  [16]
showed that there was no significant difference in total  IgE level  between patients with
Parasitic Diseases - Schistosomiasis98
acute and chronic schistosomiasis. In addition, Caldas et al [21] showed that specific IgG,
IgM and IgE titers  against  egg and worm antigens in acute patients  do not  differ  from
those presented by chronic  patients.  Regarding cellular  immunological  events,  nitric  ox‐
ide  (NO)  represents  an  important  and versatile  messenger  in  biological  systems,  and it
has been identified as a cytotoxic factor in the immune system, presenting anti-  or pro-
inflammatory  properties  under  different  circumstances  [22].  Oliveira  et  al.  [23]  demon‐
strated  that  human  peripheral  blood  mononuclear  cells  (PBMC)  are  capable  of  in  vitro
NO production and the inhibition of its production through the addition of N omega-ni‐
tro-L-arginine  methyl  ester  (L-NAME)  is  responsible  for  an  exacerbated  granulomatous
reaction.
In this report, we evaluated the clinical/laboratorial parameters and ultrasonographic fea‐
tures of patients who suffered acute schistosomiasis resulting from a simultaneous expo‐
sure in a country house in the metropolitan area of Belo Horizonte,  Minas Gerais State,
Brazil.
2. Population, materials and methods
2.1. Study population
The patients evaluated in this study acquired the acute phase of S. mansoni infection in a
country house in the rural district of the municipality of Igarapé in the metropolitan area
of  Belo  Horizonte,  Brazil.  The  country  house  is  frequently  leased during  the  weekends
and long holidays. It is a large house with a pool of water supplied by a stream. Beside
the pool, the water from the stream was channeled into open channels to form a shower.
During the inspection of the country house, researchers at the Research Center Rene Ra‐
chou (CPqRR) – Oswaldo Cruz Foundation, at the Brazilian Ministry of Health detected
that the place did not have basic sanitation.  All  the water used was damped, discarded
in a dam located near the house. Out of forty-two individuals who were in the country
house, thirty-eight participated in the study and were previously evaluated. After a pre‐
liminary assessment, we found that nineteen infected patients had been treated previous
to our evaluation and five patients did not fulfill  the inclusion criteria described below.
Therefore,  these  patients  were  excluded  from  the  study  apart  from  other  four  subjects
who had negative stool examination for S. mansoni.  Thus, the group of patients evaluat‐
ed  was  composed by  ten  individuals,  five  women and five  men,  aging  14  to  31  years,
with parasite load ranging from 8 to 768 eggs per gram of feces (epg).
To participate in the study,  patients  in the acute phase of  schistosomiasis  have fulfilled
the following criteria for inclusion:  age between 10 and 65 years;  did not report  having
received  any  treatment  with  anti-helminthic  drugs  in  the  last  24  months;  diagnosis  of
acute schistosomiasis mansoni based on epidemiological data (recent contact with S. man‐
soni  cercariae-contaminated water),  clinical symptoms (acute enterocolitis,  nausea, vomit‐
ing,  abdominal  pain,  fever,  headache,  weight  loss,  cough,  cercarial  dermatitis,
hepatomegaly and splenomegaly) and laboratory data (eosinophilia and viable S. mansoni
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eggs in  stool).  Each volunteer  or  their  legal  guardian signed their  informed consent.  In
addition,  we  also  excluded  from  this  study  all  patients  who  had  one  of  the  following
conditions: unable to hold examinations proposed; alcoholism, defined as above average
weekly consumption of  420  grams of  ethanol  (daily  average over  60  g  of  ethanol)  [24];
pregnancy,  defined by laboratory criteria;  significant anemia defined as hemoglobin less
than 10 g/dl [25] and any other significant systemic disease, acute or chronic, that could
interfere with the results of the proposed methods.
After blood collection, all patients who had positive stool examination for S. mansoni, regard‐
less of participation in the study, were submitted to treatment with the standard Brazilian dose
of Praziquantel (50-60 mg/kg).
A group of healthy volunteers formed by nine individuals, one woman and eight men aged
25 to 42 years, blood donors of the blood bank of Hospital Felicio Rocho, Belo Horizonte, Minas
Gerais, Brazil constituted a control group (CT). It is important to mention that these individuals
were screened and selected after serological tests for negativity for Chagas disease, leishma‐
niasis, human immunodeficiency virus (HIV), hepatitis, and did not report previous infection
with S. mansoni.
The study was carried out according to the National Health Council resolution 196/96, which
regulates the research involving human beings, and was approved by the Ethics Committees
of the Faculty of Medicine, Federal University of Minas Gerais, Oswaldo Cruz Foundation,
and the Brazilian National Committee on Ethics in Research.
2.2. Parasitological examination
Parasitological examination was performed using the Kato-Katz method [26]. The presence
and the number of S. mansoni eggs per gram of feces were determined through examination
of six blades per one stool sample for each patient. The results are presented as the arithmetic
mean of number of eggs. The Kato-Katz method is the method of choice to measure infection
level and has been used extensively in epidemiological studies.
2.3. Evaluation of clinical parameters
All the individuals who came into contact with water contaminated by cercariae were
subjected to a detailed history, performed by a physician of our team. The survey used during
this study contained data referring to number of the protocol, name, gender, age, education
and place of birth and questions about the clinical symptoms/signs such as fever, diarrhea,
nausea, vomiting, abdominal pain, cough, weight loss, headache, asthenia, facial edema and
cercarial dermatitis.
2.4. Evaluation of hematological parameters
Peripheral blood was collected in 5 mL vacuum tubes containing ethylenediamine tetraacetic
acid (EDTA) as anticoagulant (Vacutainer, Beckton Dickinson, CA, USA), approximately 40
days after contact with contaminated water by cercariae and only once prior to treatment with
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praziquantel. The hemograms were performed in automated hematological electronic counter
(Coulter MD18, E.U.A). The parameters measured were hemoglobin, number of erythrocytes
and hematocrit values as well as total and differential counts of leukocytes including absolute
counts of eosinophils, neutrophils, lymphocytes and monocytes.
2.5. Total IgE measurement
The plasma levels of total IgE antibodies were quantified using Colorimetric Immunoenzy‐
matic kit  (SYM Total IgE, Symbiosis Diagnostic, Brazil). Aliquots of 25 µL of plasma and
six standards (Reagent kit SYM Total IgE Symbiosis Diagnostic, Brazil) at concentrations
of 0, 5, 25, 50, 150 and 400UI/mL were dispensed in duplicates in wells of flat-bottomed
plates, previously sensitized with streptavidin, together with 100 µL of monoclonal anti-
human IgE conjugated to  biotin  (Reagent  kit  SYM Total  IgE Symbiosis  Diagnostic,  Bra‐
zil).  The  plates  were  incubated  for  30  minutes  at  room  temperature  in  the  dark  and
washed five times with 300 µL/well  of  wash solution (Reagent kit  SYM Total  IgE Sym‐
biosis Diagnostic, Brazil). Subsequently were added 100 µL of a second monoclonal anti-
human IgE conjugated to peroxidase. The plates were incubated for 30 minutes at room
temperature,  in  the  dark,  and  washed  five  times  with  300  µL/well  of  wash  solution.
Then,  100  µL  of  chromogen-substrate  solution  (tetramethylbenzidine-TMB)  (Reagent  kit
SYM Total IgE Symbiosis Diagnostic,  Brazil)  were added by well,  and the plate was in‐
cubated for 15 minutes in the dark.  The reaction was stopped by adding 100 µL of  1N
sulfuric acid (H2SO4) per well (Reagent kit SYM Total IgE Symbiosis Diagnostic, Brazil).
The optical density of samples and standards was measured in an automatic reader (Mo‐
lecular Devices Versa Max, California, USA) using a 450 nm filter.
2.6. Nitric oxide plasma levels
The plasma levels of nitric oxide were quantified using Immunoenzymatic kit QuantiChromTM
Nitric Oxide (Quantitative Colorimetric Determination of Nitric Oxide, BioAssay Systems,
USA). The assays were performed according to the manufacturer's recommendations. The
deproteination of samples was made by adding 80 mL of zinc sulfate (ZnSO4) 75 mM final
concentration and 120 mL of sodium hydroxide (NaOH) 55 mM final concentration. Samples
were centrifuged at 400 g for 5 minutes at 4°C. Then 70 mL of glycine buffer was added in each
sample. Afterwards, aliquots of 100 µL of plasma and eight standards at concentrations of 0,
5, 10, 15, 20, 30, 40 and 50 µM mL were dispensed in duplicates in 1.5 mL tubes. Then, samples
were placed in the presence of cadmium activated with 200 mL of Buffer Activation and
incubated for 15 minutes. The samples were transferred in duplicates to their respective wells
in flat-bottomed plates and added to 50 mL of reagents A and B. The optical density of samples
and standards was measured in an automatic reader (Molecular Devices Reader-Precision,
USA) using a 540 nm filter.
2.7. Evaluation of hepatic enzymes
For the analysis of hepatic functions for the study group, plasma concentration of the en‐
zymes  ALT  (alaline  amino  transferase),  AST  (aspartate  amino  transferase)  and  γ-GT
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(gamma-glutamyl  transferase)  were  quantified  by  kinetic  method  using  ALT/GPT Liqui‐
form, AST/GOT Liquiform and GAMA GT Liquiform kits  (Labtest  Diagnostic,  Brazil)  in the
device  Wiener  Lab  Metrolab  2300  plus  (Model  CM-200).  The  results  were  expressed  in
UI/mL.
2.8. Ultrasonographic analysis
Ultrasonographic  evaluation was performed using a  Nemio SSA/550ª  machine (Toshiba,
Town, Japan) with a 3-MHz sector probe for patients ≥ 10 years old and a 5-MHz probe
for  patients  under  10  years  old.  The  group of  healthy  individuals  non-infected  with  S.
mansoni  (CT group)  consisted of  twelve  volunteers,  paired by sex  and age  with  the  in‐
fected patients. Seven acute patients, three women and four men aged 14 to 31 years old
have had ultrasonographic evaluation.  All  study population was examined by the same
physician (MCBA). Liver size, portal-vein diameter, thickness of the central walls and pe‐
ripheral portal branches, spleen size and splenic vein diameters were assessed as descri‐
bed [27,  28].  The liver  was  also  examined for  surface  smoothness.  Portal  vein  diameter
was  measured  at  its  entrance  into  the  liver  and  its  bifurcation  inside  the  liver.  The
spleen was evaluated by using oblique and longitudinal scanning of the left upper quad‐
rant.  The gallbladder was examined for wall  thickness and stones.  The periportal  thick‐
ness was evaluated according to previous established criteria by [27-29].
2.9. Statistical analysis
The statistical analysis of the data was made through GraphPad PRISM® 5.00 software release
for Windows (La Jolla, CA, USA). Student's t test was used for parametric data comparison
between two groups, while for non-parametric data we used the Mann-Whitney test. In all
cases, the data were considered significant at P < 0.05.
3. Results
3.1. Demographic data and intensity of S. mansoni infection
Out of forty-two people who were present in the country house, thirty-eight (90.5%) partici‐
pated in this study and reported contact with water contaminated with cercariae. Out of these,
thirty-four (89.5%) had eggs of S. mansoni in their feces and four (10.5%) were repeatedly
negative. According to criteria previously mentioned, twenty-four patients were excluded
from the study and ten patients were considered to be on an ongoing acute phase of schisto‐
somiasis. In the acute group (ACT), there were no significant differences in age between
females and males (23.0 ± 7.8 and 19.8 ± 4.5 years old, respectively, p value = 0.45) and the
intensity of infection did not differ regarding gender, (205.6 ± 318.5 and 98.4 ± 70.7 eggs/g of
feces, respectively, P value = 0.50). The ACT group presented parasite load ranging from 8 to
768 eggs per gram of feces (152.0 ± 224.7).
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Parameter
Subjects
Total individuals Evaluated individuals Acute patients
Number of subjects (%) 42 (100%) 38 (90.5%) 10 (23.8%)
Age
Range 01 - 65 01 - 65 14 - 31
Mean ± SD 22.4 ± 15.2 22.5 ± 15.5 21.4 ± 6.2
Median 21.5 20.5 22.5
Gender
Female 25 (59.5%) 22 (57.9%) 05 (50.0%)
Male 17 (40.5%) 16 (42.1%) 05 (50.0%)
Parasitological Examination
Negative ---- 04 (10.5%) 0
Positive ---- 34 (89.5%) 10 (100%)
Egg counts (eggs/g of feces)
Range ---- 0 - 768 8 - 768
Mean ± SD ---- 50.8 ± 132.2 152.0 ± 224.7
Median ---- 10.0 86.0
Table 1. Characterization of the study population
3.2. Clinical manifestations
The magnitude of clinical manifestations of schistosomiasis varies from light to severe
intensity. Two patients showed serious clinical symptoms and required hospitalization due to
the severity of the disease. The patients reported the onset of symptoms 20-30 days after water
exposure. Headache and fever (60.0% and 50.0%, respectively) were the most common
symptoms among patients, followed by diarrhea and weight loss (both 40.0%). Other clinical
symptoms/signals were also recorded such as nausea/vomiting, abdominal pain, cough,
asthenia, facial edema (each one with frequency of 30.0%) as well as urticaria and cercarial
dermatitis (both 10.0%).
Table 2 highlights the main features observed in different human studies evaluating acute
phase of schistosomiasis mansoni performed in distinct brazilian states such as Pernambuco,
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Sergipe and Minas Gerais. Although in these studies the frequency of exposed/infected
individuals was similar ranging 90-100% and the incubation period has also occurred in
comparable times such 20-30 days, we have observed strongly heterogeneous symptoms
between them. Nonetheless, our study demonstrated some similar clinical symptoms in
comparison to those found by Barbosa et al. 2001b [30] like the frequency of fever (50.0% and
54.0%, respectively), cough (30.0% and 33.0%, respectively) and urticaria (10.0% and 8.0%,
respectively). However, other parameters presented distinct results like the frequency of
headache (60.0% and 33.0%, respectively) and diarrhea (40.0% and 25.0%, respectively).
Parameters Barbosa Et Al.2001a [15]
Barbosa Et Al.
2001b [30]
De Jesus Et Al.
2002 [16] This Study
Number of patients 11 12 31 10







Exposed/infected 92% 100% 92% 90%
Incubation period
(days) 15-30 20 20-30 20-30
Headache 36% 33% 87% 60%
Fever 100% 54% 90% 50%
Diarrhea 64% 25% 81% 40%
Cough 91% 33% 91% 30%
Abdominal pain 64% N.E. 93% 30%
Urticaria 18% 08% N.E. 10%
Cercarial dermatitis 100% N.E. N.E. 10%
Hepatomegaly 75% N.E. 35% 86%
Transaminases
(increase) 36% N.E. 38% N.L.
N.E. - not evaluated
N.L. - normal levels
Table 2. Main features observed in different human studies evaluating the acute phase of schistosomiasis mansoni
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3.3. Plasma levels of total IgE and nitric oxide
The plasma levels of total IgE and nitric oxide from the ACT group are illustrated in Figure
1. The analysis of the results showed that the ACT group presented a significant (P < 0.05)
increase of these parameters as compared with the CT group.
3.4. Hematological profile
The main findings related to the hematological profile from the ACT group are illustrated in
Figures 2 and 3. The analysis showed a significant reduction in the concentration of hemoglo‐
bin in the ACT group as well as an increase in the total leukocytes count as compared with the
CT group. Increased total leukocytes were reflected in the absolute values of lymphocytes and
eosinophils also increased in the ACT group as compared with the CT group. No significant
difference was found between these two groups regarding other analyzed parameters such as
number of erythrocytes, percentage of hematocrit, and absolute values of neutrophils and
monocytes.
Figure 1. Total plasma IgE and nitric oxide (NO) levels in acute schistosomiasis patients (ACT=10) and non-infected
individuals (CT=09). The results are expressed in box-plot format. The box stretches from the lower hinge (defined as
the 25th percentile) to the upper hinge (the 75th percentile) and therefore contains the middle half of the scores in
the distribution. The median is shown as a line across the box. Therefore 1/4 of the distribution is between this line
and the top of the box and 1/4 of the distribution is between this line and the bottom of the box. Significant differen‐
ces (connecting lines) were considered at P < 0.05.
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Figure 2. Hematological profile (hemoglobin-g/dL, erythrocytes/mm3 and percentage of hematocrit) from acute
schistosomiasis patients (ACT=10) and non-infected individuals (CT=09). The results are expressed in box-plot format.
The box stretches from the lower hinge (defined as the 25th percentile) to the upper hinge (the 75th percentile) and
therefore contains the middle half of the scores in the distribution. The median is shown as a line across the box.
Therefore 1/4 of the distribution is between this line and the top of the box and 1/4 of the distribution is between this
line and the bottom of the box. Significant differences (connecting lines) were considered at P < 0.05.
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Figure 3. Total and differential leukocyte counts from acute schistosomiasis patients (ACT=10) and non-infected indi‐
viduals (CT=09). The results are expressed in box-plot format highlighting the gap of 50% of data set measurement
for absolute values in mm3 of each leukocyte subset analyzed. Significant differences (connecting lines) were consid‐
ered at P < 0.05.
3.5. Profile of hepatic enzymes
Acute patients presented levels of ALT, AST and γ-GT enzymes similar to reference values
and there were no significant differences between these levels and those presented by CT
group. (Table 3).
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Hepatic Enzymes Control Group(N = 9)
Acute Patients
(N = 8)
ALT (alaline amino transferase)
(3-50 U/mL)* 12.5 ± 11.2 8.6 ± 5.5
AST (aspartate amino transferase)
(12-46 U/mL)* 18.7 ± 5.9 23.0 ± 6.7
γ-GT (gamma-glutamyl transferase)
(9-61 U/L)* 23.4 ± 9.9 33.9 ± 16.6
Values are represented as mean ± standard deviation
* Reference values
Table 3. Hepatic serological tests in the study group
3.6. Ultrasonographic analysis
The results demonstrated that the ACT group presented some significant differences as
compared with the CT group: medium increase in the measurement (in mm) of longitudinal
left/right lobe of liver (117.4 ± 19.7 and 99.0 ± 12.3 or 150.1 ± 18.2 and 102.2 ± 16.0, respectively),
size of longitudinal spleen (110.6 ± 16.3 and 91.2 ± 12.7, respectively) as well as dimension of
Hilar portal vein wall (3.4 ± 1.0 and 1.5 ± 0.3, respectively) (Table 4). Periportal lymph node
enlargement was observed in six of seven patients (85.7%). The periportal lymph nodes were
larger, round or ovoid in shape and sharply defined with thin halos surrounding hypoechoic
areas (Figure 4). An additional ultrasonographic feature observed was an incipient periportal
echogenic thickening named as grade I fibrosis (Figure 5).
Site Of Measurement Control Group(N = 12)
Acute Patients
(N = 7)
Longitudinal left lobe of liver 99.0 ± 12.3 117.4 ± 19.7*
Anteroposterior left lobe of liver 46.7 ± 10.0 53.3 ± 10.9
Longitudinal right lobe of liver 102.2 ± 16.0 150.1 ± 18.2*
Anteroposterior right lobe of liver 68.6 ± 11.9 63.4 ± 9.6
Longitudinal spleen 91.2 ± 12.7 110.6 ± 16.3*
Anteroposterior spleen 35.1 ± 6.3 43.5 ± 11.1
Portal vein 10.0 ± 1.2 9.9 ± 1.9
Hilar portal vein wall 1.5 ± 0.3 3.4 ± 1.0*
Splenic vein 6.4 ± 1.3 7.1 ± 1.4
Superior mesenteric vein 6.7 ± 1.1 7.1 ± 1.3
Periportal lymph node N.V. 1.8 ± 1.0*
Values are represented in mm as mean ± standard deviation
* Statistical difference (p < 0.05)
N.V. - not visualized (normal abdominal lymph nodes are usually not visualized by sonography)
Table 4. Ultrasonographic features of the study group
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Figure 4. Representative ultrasonographic images of periportal lymph nodes from acute schistosomiasis patients. The
arrows indicate larger lymph nodes, ovoid in shape (a) and rounded (b) with thin halos surrounding hypoechoic areas.
Ultrasonographic analysis was performed with a Nemio SSA/550ª machine (Toshiba).
Figure 5. Representative ultrasonographic images of liver from acute schistosomiasis patient (a) and healthy volunteer
(b). The arrows indicate incipient periportal echogenic thickening (a) and no periportal echogenic thickening (b). Ul‐
trasonographic analysis was performed with a Nemio SSA/550ª machine (Toshiba).
4. Discussion
The transmission of S. mansoni may vary depending on the ecology of the disease and the social
standing of the population in which it occurs. The prevalence and intensity of the infection is
subject to cultural practices, specific for each locality or situation and usually associated to
economic, domestic or leisure activities [15, 31].
During  the  last  decades,  the  traditional  epidemiological  pattern  showed  a  tendency  to
change.  Accelerating  migration  from  the  countryside  to  cities  threatened  to  overwhelm
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existing water  and sanitation systems,  and to  increase  urban schistosomiasis  [9,  32,  33].
In  Brazil,  especially  in  urban areas,  acute  schistosomiasis  outbreaks  were  observed and
documented with a certain frequency [9, 14, 15, 17, 34-36]. The increase of acute schisto‐
somiasis  cases  also  indicates  that  a  non-immune  fraction  of  the  population  became ex‐
posed to the disease [9, 10, 36].
The incidence of the acute form of schistosomiasis mansoni is certainly underestimated. This
illness has been mainly described as a disease of travelers. Many scientific publications
concerning this acute disease refer to groups of tourists, fishermen or sailors originally from
a non-endemic country who have visited a tropical zone [17, 37, 38]. However, as schistoso‐
miasis is a focally distributed infection [17, 39, 40], the acute form is also diagnosed in inhab‐
itants from endemic countries who do not live in endemic areas. Nevertheless, acute disease
is seldom recognized in infected patients from endemic areas. According to Lambertucci [41],
acute schistosomiasis is most evident in primary infection in non-immune individuals. Among
people living in endemic areas, the acute phase may pass undiagnosed. Because in endemic
areas exposure to infection occurs early in life, symptoms would be inconspicuous and
diagnosis not even suspected.
The clinical features of the acute phase of schistosomiasis mansoni present a wide spec‐
trum [42, 43] and the relative contribution of host and parasite factors in the pathogene‐
sis  of  the  disease  is  not  completely  elucidated [20,  43-45].  According to  Neves  [46],  the
clinical  forms  of  the  disease  will  depend on  the  interaction  of  at  least  three  sequential
events: (a) the evolution phase of the worms, whether before or after oviposition and the
deposition of eggs in the tissues; (b) the organ predominantly involved by young or ma‐
ture worms and by their eggs; and (c) the type and the qualitative/quantitative deviation
of the total and local host response to antigenic products derived from the disintegration
of schistosomula, adult worms and their eggs.
The main clinical findings presented in our study such as headache, fever, diarrhea and weight
loss were consistent with those found by other authors [9, 15-17]. Different intensities of clinical
manifestation are observed in patients with acute schistosomiasis, some of them evolved with
a relatively severe picture while others with mild symptoms. In our study, we have also
observed a similar profile.
The development of  non-apparent clinical  form characterized by blood eosinophilia  and
a  positive  immediate  cutaneous  reaction  in  the  initial  phase  of  the  S.  mansoni  infection
was described by Rocha et  al.  [47].  According to previous data in the literature [13,  15,
16, 43], patients with acute phase of schistosomiasis in our study had an increased abso‐
lute number of  eosinophils  in comparison to reference data ranging between 400 to 600
cells/mm3  [48].  Eosinophils  are  thought  to  play a  major  role  in a  variety of  human dis‐
eases, including allergic inflammation, malignancy, and host defense against helminth in‐
fections.  However,  the  exact  role(s)  of  eosinophils  in  schistosomiasis  regarding
immunopathology remains unclear. Eosinophils may participate in Ab-dependent protec‐
tive immune responses [49]. Human eosinophils express IgE receptors that participate in
an IL-5-dependent Ab-dependent cell-mediated cytotoxicity reaction against schistosomu‐
la  in  vitro.  Eosinophils  also  mediate  the  destruction  of  miracidia  and schistosome eggs
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[50]. Experimental studies have shown that the eosinophilia would be induced by type 2-
cytokines as interleukin (IL)-4, IL-9, IL-13 and mainly by IL-5 [51]. According to Rocha et
al. [43], the eosinophilia may be considered a possible pathogenic factor in acute schisto‐
somiasis. The specific granules of the eosinophil contain lysosomal hydrolases as well as
several  cationic proteins like the major basic  protein (MBP) [43,  52],  the eosinophil  cati‐
onic protein (ECP) and a neurotoxin, the eosinophil-derived neurotoxin (EDN), besides a
peroxidase [43, 53]. The MBP in low concentrations is toxic to schistosomula but this ac‐
tion is non-selective since mammalian cells can also be damaged [43, 54, 55]. Both perox‐
idase and ECP are also toxic for helminths and mammal cells [43,  56,  57].  The cytolysis
or  eosinophil  degranulation  with  the  release  of  granule  proteins  can  contribute  to  the
genesis of local pathological alterations causing dysfunction or damage to the cells, espe‐
cially when a great number of eosinophils are involved [43, 53, 58].
According to this report, acute patients presented increased plasma levels of IgE and ni‐
tric oxide as compared with the CT group. Our result is similar to the data published by
De Souza et al. [59], which evaluated the humoral immune response through quantifying
of the total IgE levels from patients with acute clinical form of schistosomiasis. Thus, we
suggest  that  total  IgE may be  related to  disease  morbidity,  as  established by Pereira  et
al. [60]. Nitric oxide (NO) has been identified as an important cytotoxic factor and versa‐
tile  messenger  in  the  immune  system  being  responsible  to  induce  both  anti-  and/or
proinflammatory effects [61].  There are broad direct and indirect evidences that NO can
act  as  an  anti-schistosomal  and  antiparasitic  molecule  [62-64].  Moreover,  NO  produced
by human leukocytes has been shown to kill  larval schistosome parasites [64,  65].  Stud‐
ies  in  experimental  models  of  acute  schistosomiasis  showed that  the inhibition of  iNOS
resulted in cachexia and exacerbated hepatic pathology, suggesting that in schistosomia‐
sis, NO limits hepatocyte damage [66-68].
From two to eight weeks after a first  contact with natural  water infested by Schistosoma
cercariae, susceptible infected patients may present a syndrome comprising a period of 2
to 30 days of fever, diarrhea, toxemia and weakness, weight loss, abdominal pain, cough,
mialgya,  and arthralgia,  edema,  urticaria,  nausea/vomiting  and hepatosplenomegaly  [7].
Until  recently,  acute  schistosomiasis  diagnosis  was  only  based  on  epidemiological  and
clinical features, presence of S. mansoni eggs in stools and eosinophilia. However, the di‐
agnosis  becomes  a  challenge  to  the  physicians  due  to  the  non-specificity  symptoms  as
well as the lack of positivity of the subjects for S. mansoni eggs in feces in earlier stage of
the infection.  In this  context,  abdominal  ultrasound can be a  complementary tool  to  as‐
sist the diagnoses of the S. mansoni  infection. The ultrasonographic findings presented in
this  study were  consistent  with  those  described by Barata  et  al.  [11].  According to  this
report,  ultrasonographic evaluation showed non-specific  increase in the size of  liver,  in‐
cipient  periportal  echogenic  thickening,  in  addition  to  lymph nodes  easily  identified  in
the periportal region. The authors have also performed a histological liver analysis from
hepatic biopsies of three patients, and the data demonstrated that the periportal thicken‐
ing seen on ultrasound was probably produced by inflammatory infiltration of the portal
tracts  caused  by  schistosomiasis,  which  disappeared  after  treatment  with  oxamniquine.
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However, liver biopsy is an invasive procedure that is seldom justified. It is important to
mention that the ultrasonographic features of the lymph nodes, liver and spleen in acute
schistosomiasis,  although highly sensitive, are not pathognomonic of acute schistosomia‐
sis,  and are also seen in other infectious diseases such as acute hepatitis and other viral
diseases [19, 69, 70].
Normal  abdominal  lymph  nodes  are  usually  not  visualized  by  sonography.  Neoplastic
lymph nodes are generally rounded and hypoechoic,  sometimes with an irregular shape
and borders [19, 71, 72]. Lymphomas can also affect periportal and peripancreatic lymph
nodes, but there is generally an extensive involvement of other abdominal lymph nodes,
mainly  retroperitoneal,  that  is  almost  anechoic  and  usually  rounded.  In  this  circum‐
stance,  the  liver  and  spleen  are  enlarged  and  can  show  focal  lesions  [19,  72].  Patients
with  acquired immunodeficiency syndrome (AIDS)  can also  show hepatoesplenomegaly
and abdominal lymphadenopathy,  but the echogenicity of the liver is  usually increased.
Tumors related to AIDS, such as Kaposi’s sarcoma, have also been reported as a cause of
lymphadenopathy [73]. Mesenteric and periportal lymphadenomegaly is a common find‐
ing in blastomycosis and these are almost anechoic [19].
In the current  study,  we have also evaluated the liver  function of  acute schistosomiasis
patients by the ALT, AST and γ-GT assessment. Comparing with other studies in litera‐
ture  [15,  16],  we did not  observe  changes  in  any of  the  enzymes evaluated,  suggesting
that  the  hepatocellular  function  is  preserved  or  minimally  compromised  in  the  study
population. In patients presenting intestinal or hepatointestinal clinical form of schistoso‐
miasis,it has been observed that the liver function is maintained. In those patients show‐
ing the hepatosplenic  form,  liver  function related to  protein metabolism was in  general
changed, but rarely this function is compromised in a broad spectrum. Only after repeat‐
ed  blood spoliation,  in  the  terminal  stage  of  illness,  there  is  strong involvement  of  the
liver parenchymal. According to some authors, when liver cell damage occurs there is an
increase of ALT and AST levels, but in the S. mansoni  infection this type of injury is not
commonly observed [74, 75]. On the other hand, the most important cause of increased
γ-GT levels is the chronic stimulation of the microsomal fraction of hepatocytes and the
presence of cholestasis [76]. According to Martins & Borges [77], the chronic stimulation of the
microsomal occurs only in patients with hepatosplenic form of schistosomiasis. Kardorff et al.
[74] observed that the increase of γ-GT occurs only in patients with severe periportal fibrosis,
irregular texture liver and collateral vessels.
5. Conclusion
In conclusion, the data presented here suggest that alterations identified by analyses of clinical/
laboratorial parameters and ultrasonographic features, although not specific, are compatible
with the acute phase of Schistosomiasis mansoni and provide a reliable complementary tool
for the diagnosis of the infection.
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